Trump withdraws Heidi Overton as nominee to lead Food and Drug Administration, sources say
U.S. President Donald Trump has withdrawn the nomination of Heidi Overton to lead the Food and Drug Administration due to insufficient support in Congress.
US President Donald Trump has withdrawn the nomination of Heidi Overton to lead the Food and Drug Administration (FDA), sources reveal. The decision comes just a day ahead of a crucial Senate committee vote on her nomination. With Republicans holding a narrow one-vote edge on the panel, the withdrawal placed Overton's nomination in jeopardy due to a potential single GOP defection.
The White House is now contemplating Senator Roger Marshall of Kansas, a former obstetrician and recent Senate election loser, as a potential replacement nominee. Overton, a preventive medicine physician and White House Domestic Policy Council deputy director, was first nominated in August following the resignation of former FDA Commissioner Marty Makary.
However, her nomination faced numerous challenges from the outset, with mounting doubts about Senate Republican support due to the party's significant losses in the recent midterm elections. Overton's ties to the Trump administration's attempts to reduce federally recommended childhood vaccinations and her vocal opposition to the abortion pill mifepristone further complicated her nomination process.
Medical groups and career FDA officials voiced concerns over her stance on these issues, leading to her withdrawal.
Written by urgent.news from Business Recorder's reporting — not their text. Machine-written — may contain errors; check the original before relying on it.
This story
This is one outlet's version. Read the fullest account.